scholarly article | Q13442814 |
P356 | DOI | 10.1097/IGC.0B013E31824F0B13 |
P698 | PubMed publication ID | 22672985 |
P50 | author | Hiroaki Itamochi | Q88144724 |
Muneaki Shimada | Q88144741 | ||
Shinya Satoh | Q91398017 | ||
Tasuku Harada | Q92368070 | ||
Tetsuro Oishi | Q93005904 | ||
Junzo Kigawa | Q95979461 | ||
Naoki Terakawa | Q114357111 | ||
Akiko Kudoh | Q117263162 | ||
Kazunori Uegaki | Q117263166 | ||
Wakae Kawaguchi | Q117266174 | ||
P2093 | author name string | Michiko Nonaka | |
Seiya Sato | |||
Jun Naniwa | |||
P433 | issue | 6 | |
P921 | main subject | cisplatin | Q412415 |
ovarian carcinoma | Q18556145 | ||
P304 | page(s) | 922-929 | |
P577 | publication date | 2012-07-01 | |
P1433 | published in | International Journal of Gynecological Cancer | Q15749181 |
P1476 | title | Activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway overcomes cisplatin resistance in ovarian carcinoma cells | |
P478 | volume | 22 |
Q36689029 | Ell3 stabilizes p53 following CDDP treatment via its effects on ubiquitin-dependent and -independent proteasomal degradation pathways in breast cancer cells |
Q38179145 | MEK1/2 inhibitors in the treatment of gynecologic malignancies. |
Q37165926 | New strategy for overcoming resistance to chemotherapy of ovarian cancer. |
Q39173323 | Notch3 induces epithelial-mesenchymal transition and attenuates carboplatin-induced apoptosis in ovarian cancer cells. |
Q34669870 | Proteomic analyses of serous and endometrioid epithelial ovarian cancers - cases studies - molecular insights of a possible histological etiology of serous ovarian cancer. |
Q28540458 | Retracted: The Inhibitory Effect of Doxycycline on Cisplatin-Sensitive and -Resistant Epithelial Ovarian Cancer |
Q28066950 | Role of Akt signaling in resistance to DNA-targeted therapy |
Q40751673 | Targeting nuclear factor-kappa B to overcome resistance to chemotherapy. |
Q40714885 | Tempol protects human lymphocytes from genotoxicity induced by cisplatin |
Q92556126 | Wogonin Increases Cisplatin Sensitivity in Ovarian Cancer Cells Through Inhibition of the Phosphatidylinositol 3-Kinase (PI3K)/Akt Pathway |
Search more.